Nova Patents
AT209907T

Liquid drug delivery compositions

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

38 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
22514094United States of AmericaA
22514094United States of AmericaA
9503792United States of AmericaW
9503792United States of AmericaW
225140
9503792
US19940225140
WO1995US03792

Members38

Family members, oldest first
DocumentOfficeKind
CA2187353A1CanadaA1
CA2582666A1CanadaA1
WO9527481A1World Intellectual Property Organization (WIPO)A1
AU2129495AAustraliaA
EP0754032A1European Patent Office (EPO)A1
KR970702029ARepublic of KoreaA
BR9507313ABrazilA
JPH09511741AJapanA
MX9604634AMexicoA
AU684931B2AustraliaB2
NZ283282ANew ZealandA
US5744153AUnited States of AmericaA
US5759563AUnited States of AmericaA
US5780044AUnited States of AmericaA
EP1125577A2European Patent Office (EPO)A2
EP0754032B1European Patent Office (EPO)B1
AT209907TThis recordAustriaT
ATE209907T1AustriaT1
DE69524398D1GermanyD1
DK0754032T3DenmarkT3
PT754032EPortugalE
DE69524398T2GermanyT2
ES2171186T3SpainT3
EP1125577A3European Patent Office (EPO)A3
KR100374098B1Republic of KoreaB1
EP1125577B1European Patent Office (EPO)B1
AT317690TAustriaT
ATE317690T1AustriaT1
DE69534780D1GermanyD1
DK1125577T3DenmarkT3
ES2258495T3SpainT3
DE69534780T2GermanyT2
CA2187353CCanadaC
JP2009029821AJapanA
JP4259610B2JapanB2
CA2582666CCanadaC
JP4974987B2JapanB2
BR9507313B8BrazilB8